baber/WOPTO huggingface dataset:
Patent EP-3654926-A2 (EP)
Title: Controlled release polymer encapsulated fragrances
Inventor: GUERRY RAYMOND E
IPC: A61K8/11
Filed: 2018-07-19
Abstract: The present disclosure relates to fragrance materials encapsulated within polymeric materials in the form of microcapsules of polymer encapsulated fragrance. The microcapsules are mixed with a water-based binding agent so that a coating forms on the microcapsule  in situ , after which the coated microcapsules may be applied to hard surfaces of a product, from which controlled release of the fragrance is provided over time as the product is subjected to normal handling by a user.
Patent EP-3703751-A2 (EP)
Inventor: HOFFMAN LENKA
IPC: A61P35/02
Filed: 2018-11-02
Abstract: The disclosure provides, e.g., enucleated erythroid cells comprising an amino acid degradative enzyme such as asparaginase and a targeting moiety such as an anti-CD33 antibody molecule. The cells may be used, e.g., to treat cancers such as AML.
Patent EP-3682892-A2 (EP)
Title: Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
Inventor: CHO DAE HO
IPC: A23L33/18
Filed: 2018-09-14
Abstract: The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.
Patent EP-3518078-A2 (EP)
Inventor: LACROIX ROBERT A
IPC: G06F3/01
Filed: 2019-01-23
Abstract: A user interface device having a haptic actuator, a sensor, a storage device, and a control circuit is presented. The sensor is configured to measure movement output by the haptic actuator. The control circuit is configured to apply a first drive signal to the haptic actuator to generate a first haptic effect, and to receive a sensor measurement that describes movement of the haptic actuator in response to the first drive signal, and to generate or update, based on the measurement, an actuator model that describes how the haptic actuator moves in response to drive signals. The control circuit is further configured to generate a second drive signal based on a desired movement for a second haptic effect and based on the actuator model, and to control the haptic actuator to generate the second haptic effect by applying the second drive signal to the haptic actuator.
Patent EP-3946511-A2 (EP)
Title: Modular mammalian body implantable fluid flow influencing device and related methods
Inventor: GEORGES GABRIEL
IPC: A61M60/865
Filed: 2020-05-04
Abstract: Modular mammalian body implantable fluid flow influencing device, comprising: docking unit having receiving surface, distal and proximal ends, proximal guide hole. Functional unit having docking surface shaped to mate with receiving surface, distal and proximal ends. Control wire extends from proximal end of functional unit then goes through guide hold then extends proximally away from docking unit. Functional and docking units are dimensioned and shaped to be deliverable to an implantation site via catheter. Functional unit has docked configuration in which docking surface mates with receiving surface of docking unit and undocked configuration in which docking surface is unmated with and spaced apart from receiving surface of docking unit. Functional unit moveable at implantation site between undocked and docked configurations via movement of control wire. Functional unit moveable into docked configuration by pulling control wire, and moveable from into undocked configuration by pushing control wire. Multiple functional units also disclosed.
Patent EP-4044842-A2 (EP)
Inventor: ATKINS ARIEL
IPC: A24F40/48
Filed: 2020-10-14
Abstract: Microfluidic features regulate the flow of fluids in a cartridge for a vaporizer device. The microfluidic features prevent leaks of liquid vaporizable material and enhance the functioning of the cartridge when there is a differential pressure between a storage chamber containing the liquid vaporizable material and ambient conditions outside the cartridge. Related systems, apparatuses, and processes, are also described.
Patent EP-3954703-A2 (EP)
Inventor: JOHNSON LESLIE S
IPC: C07K16/30
Filed: 2015-05-29
Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.
Patent EP-3991665-A2 (EP)
Title: Biopsy system with a core collector that remains radially centered in an outer  cannula while severing a tissue sample
Inventor: DENES BELA
IPC: A61B10/02
Filed: 2021-10-28
Abstract: A core collector is shaped as a crescent in cross-section and has lateral sides formed into axially extending rows of axially spaced teeth. The arc angle of the crescent shape is sufficient to keep the core collector radially centered in a cannula by having the crescent's lateral sides bear against the inside of the cannula. The set of a core collector and cannula can be used in a known biopsy system to replace the known cannula and core collector of can be used in a new core biopsy instrument.
Patent EP-4106733-A2 (EP)
Inventor: RZASA JOANNA
IPC: A61K9/20
Filed: 2021-02-10
Abstract: L'invention concerne un granulé de ramipril stable et une composition pharmaceutique à dose fixe comprenant une combinaison de ramipril et d'au moins une substance active cardiovasculaire telle que le fumarate de bisoprolol, l'amlodipine et/ou l'hydrochlorothiazide, l'incompatibilité des substances actives étant supprimée par l'utilisation d'un excipient spécifique à double fonction.
Patent EP-4195958-A2 (EP)
Inventor: ABI AOUN WALID
IPC: A24B15/14
Filed: 2021-08-13
Abstract: An article for use in a non-combustible aerosol provision system. A portion of the article includes a first amorphous solid material, and said portion is further surrounded by a layer or sheet of a second amorphous solid material.
Patent EP-4068593-A2 (EP)
Title: Absolute position sensing system for stepper motor mechanism
Inventor: JURIK PAVEL
IPC: H02P8/34
Filed: 2022-03-30
Abstract: A luminaire includes a luminaire mechanism, a stepper motor, an absolute multi-turn rotational position sensing system, and a control system. The stepper motor moves the luminaire mechanism. The absolute multi-turn rotational position sensing system includes absolute rotational sensors that detect absolute positions of a cam indexer on the motor shaft and an indexer wheel coupled to the cam indexer. The indexer wheel rotates by a predetermined amount in response to one full rotation of the cam indexer. The control system determines an absolute position of the luminaire mechanism based on information from the absolute rotational sensors relating to the positions of the cam indexer and the indexer wheel. The control system receives a commanded position for the luminaire mechanism and causes the stepper motor to move the luminaire mechanism to the commanded position based on the absolute position of the luminaire mechanism.
Patent EP-4040521-A2 (EP)
Title: White organic light emitting device
Inventor: SONG JAE IL
IPC: H01L51/54
Filed: 2015-04-20
Abstract: Disclosed is a white organic light emitting device (200, 300, 400, 500, 600) in which a life of a device is enhanced. In some embodiments, the white organic light emitting device (200, 300) includes a first emission part (110) between a first electrode (102) and a second electrode (104), the first emission part (110) comprising a first hole transport layer (112) and a first electron transport layer (116); and a second emission part (120) on the first emission part (110), the second emission part (120) comprising a second hole transport layer (122) and a second electron transport layer (126), wherein at least one among the first emission part (110) and the second emission part (120) comprises at least two stacked emission layers (114, 115, 124, 125) and an emission area control layer (EACL) (190, 290), wherein the at least two stacked emission layers (114, 115, 124, 125) comprise a first emission layer (115, 124) including a first dopant and a first host, and a second emission layer (114, 125) including a second dopant different from the first dopant, and wherein the EACL (190, 290) is adjacent to the at least two stacked emission layers (114, 115, 124, 125).
Patent EP-4181111-A2 (EP)
Title: Display device and method of driving the same
Inventor: HWANG JUNG HWAN
IPC: G09G3/32
Filed: 2022-11-07
Abstract: A display device includes PAM data lines receiving PAM and PWM data voltages, and sub-pixels connected to the PAM and PWM data lines. A sub-pixel includes a light emitting element, a first pixel driver to supply a control current according to one of the PAM data voltages to a node, a second pixel driver to generate a driving current according to one of the PWM data voltages, and a third pixel driver to adjust a period during which the driving current is supplied to the light emitting element according to a voltage of the node. A peak current value of the driving current when the sub-pixel emits a light corresponding to a low gray level region is smaller than a peak current value of the driving current when the sub-pixel emits a light corresponding to a high gray level region higher than the low gray level region.
Patent EP-4218769-A2 (EP)
Title: Treatment of oculopharyngeal muscular dystrophy by intravenous administration of trehalose
Inventor: MEGIDDO DALIA
IPC: A61K31/7016
Filed: 2014-05-07
Abstract: Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
Patent EP-4266740-A2 (EP)
Inventor: SIVASIVA GANESAN RAKASH
IPC: H04W28/00
Filed: 2023-03-29
Abstract: A method may include configuring a first network element and a user plane function to expose port information of a first network element and a user plane function to a backhaul network. Associated identifiers of the first network element and the user plane function may be received from a second network element. Second stream requirements may be determined in 5GS for the streams transmitted through SGS. First stream requirements may be derived for a stream to be transmitted between a talker and a listener, and talker and listener identifiers which are the identifiers of the first network element or the user plane function for the backhaul centralized network configurator. Configurations are received of the first network element and the user plane function. Additionally, a protocol data unit session modification procedure may be triggered for the stream.
Patent EP-4293395-A2 (EP)
Inventor: NÜBLING RALF ULRICH
IPC: G01V8/22
Filed: 2023-03-30
Abstract: Die vorliegende Erfindung betrifft einen optoelektronischen Sensor, umfassend eine Lichteintrittsöffnung und wenigstens einen Lichtempfänger zum Erfassen von Empfangslichtsignalen und zum Umwandeln der Empfangslichtsignale in elektrische Empfangssignale, wobei sich zwischen der Lichteintrittsöffnung und dem wenigstens einen Lichtempfänger ein Empfangslichtpfad erstreckt, welcher ein Umlenkelement mit einer vorderen und einer hinteren Reflexionsfläche aufweist, wobei das Umlenkelement derart ausgebildet ist, dass ein Teil der Empfangslichtsignale an der vorderen Reflexionsfläche und ein anderer Teil der Empfangslichtsignale an der hinteren Reflexionsfläche reflektiert werden. Erfindungsgemäß ist vorgesehen, dass die vordere Reflexionsfläche zumindest teilweise eine Filterschicht aufweist, welche Empfangslichtsignale in Abhängigkeit von ihrer Wellenlänge und/oder Polarisierungsrichtung reflektiert oder durchlässt. Die Erfindung betrifft ferner eine Lichtsenderanordnung.
Patent EP-4249065-A2 (EP)
Inventor: KORMAN ALAN J
IPC: A61P35/00
Filed: 2014-09-18
Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
Patent EP-4233969-A2 (EP)
Inventor: BORNHOFT STEPHEN
IPC: A61M25/06
Filed: 2017-03-23
Abstract: A medical device (100), comprising a hub (102) or housing (118) having a push tab (112) including a main portion extending radially from an upper surface of the hub (102) or housing (118), and at least one anti-rotation feature (114, 116) for resisting rotation of the hub (102) or housing (118). A cannula (103) is directly or indirectly connected to the hub (102) or housing (118). The medical device (100) may be a catheter, the cannula (103) may be a catheter tube, and the hub (102) or housing (118) may be a catheter hub or an introducer needle tip shield of the catheter (100).
Patent EP-4249503-A2 (EP)
Inventor: SCHREIBER TAYLOR
IPC: C07K14/47
Filed: 2018-02-27
Abstract: The present invention relates, in part, to, chimeric proteins which include the extracellular domain of V-set and immunoglobulin domain-containing protein 8 (VSIG8) and their use in the treatment of diseases, such as immunotherapies for cancer and/or inflammatory diseases.
Patent EP-4238732-A2 (EP)
Inventor: SCHWARZBAUM ARIE
IPC: B29C35/08
Filed: 2016-01-18
Abstract: A curing system for printing of 3D objects having one or more sources of curing radiation moveably attached to and flanking at least one side of an extrusion head and extrusion nozzle wherein the extrusion head and extrusion nozzle and the at least one source of curing radiation act in unison as a single unit wherein curing of deposited curable material is applied concurrently with or immediately following deposition of the curable material.
Patent EP-4236124-A2 (EP)
Inventor: SITHAMPARANATHAN SABESAN
IPC: H04K3/00
Filed: 2019-11-29
Abstract: An RFID system comprises an array of antennas each configured to emit a plurality of beams in different directions. The beams of each pair of adjacent antennas are directed towards one another and overlap. A pair of adjacent antennas transmits simultaneously and the overlapping beams interfere to create an interference pattern. An RFID reader controls the relative phase and/or frequency of the beams to move the interference pattern to read an RFID tag within the moving pattern. As the chance of a RFID tag responding to an emitted beam generally increases with signal strength of the reader beam an area of constructive interference means that RFID tags in that region are more likely to respond to the signal. The system can cover a large proportion of the area below ceiling-mounted antennas, where cover generally means that RFID tags in that area will be successfully read.
Patent EP-4272584-A2 (EP)
Inventor: MISHRA MUNMAYA K
IPC: A24D3/06
Filed: 2017-05-12
Abstract: A breakable capsule such as a seamless breakable capsule useful in a smoking article or a smokeless tobacco product includes an outer shell formed of a cross-linked agar matrix including at least one filler, and an inner core surrounded by the outer shell which comprises a liquid or gel based composition of a flavorant and/or non-flavorant. The cross-linked agar matrix is reinforced with carboxymethyl cellulose that is dispersed throughout the agar matrix so as to fill empty spaces in the agar matrix and inhibit the composition from passing through the empty spaces of the agar matrix.
Patent EP-4277190-A2 (EP)
Inventor: GAO SHIWEI
IPC: H04L5/00
Filed: 2018-10-02
Abstract: A method performed by a wireless device (702) for performing measurements in a wireless communication system (700) is presented. The method comprises receiving (2400), from a network node (704) of the wireless communication system (700), a semi-static indication of one or more first sets of Non-Zero Power, NZP, Channel State Information Reference Signal, CSI-RS, resources for channel measurement and receiving (2402), from the network node (704), a semi-static indication of one or more second sets of NZP CSI-RS resources for interference measurement, wherein each of the one or more first sets of NZP CSI-RS resources consists of a single NZP CSI-RS resource associated with one or more CSI-RS ports, each of the one or more second sets of NZP CSI-RS resources consists of one or more NZP CSI-RS resources, and each CSI-RS port associated with the one or more second sets of NZP CSI-RS resources corresponds to a Multiple User Multiple Input Multiple Output, MU-MIMO, interference layer associated with a co-scheduled user equipment. The method further comprises receiving (2404, 2406), from the network node (704), one or more dynamic indications requesting a CSI report according to a first set of NZP CSI-RS resources from the one or more first sets of NZP CSI-RS resources for channel measurement and a second set of NZP CSI-RS resources from the one or more second sets of NZP CSI-RS resources for interference measurement. Further still, the method comprises reporting (2412), in the CSI report, results of the channel measurement and the interference measurement to the network node (704).
Patent EP-4316519-A2 (EP)
Inventor: CROWELL CHRISTOPHER KENYON
IPC: A61K39/395
Filed: 2019-04-30
Abstract: This invention relates to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of denosumab molecules.
Patent EP-4284104-A2 (EP)
Inventor: TAKAHASHI HIDEAKI
IPC: H04W72/1268
Filed: 2019-10-03
Abstract: A terminal includes: a reception section that receives an uplink grant; and a control section that monitors reception of information indicating cancellation of uplink transmission in either of a period starting after a first timing at which the uplink grant is received and extending to a second timing that comes at and after a start timing of a section repeatedly transmitting an uplink data signal, the second timing being included in the section, or a period starting after the first timing and extending to a certain point prior to the section.
Patent EP-4307294-A2 (EP)
Inventor: BASTYR KEVIN J
IPC: G10K11/178
Filed: 2020-04-20
Abstract: A method for controlling stability in an active noise cancellation (ANC) system may comprise receiving, from a vehicle sensor, sensor signals indicative of current vehicle operating conditions affecting an interior soundscape of a vehicle cabin. The method may further comprise adjusting a nominal threshold for detecting ANC system divergence based on the sensor signals to obtain an adjusted threshold. The method may also comprise receiving an error signal output from a microphone located in the vehicle cabin, computing a parameter based on an analysis of at least a portion of the error signal, and modifying properties of a controllable filter in response to the parameter exceeding the adjusted threshold, the controllable filter configured to generate an anti-noise signal based on an adaptive transfer characteristic and a noise signal.
Patent EP-4301115-A2 (EP)
Title: Display device
Inventor: KIM HEEYEOL
IPC: H10K59/38
Filed: 2018-12-13
Abstract: Provided is a display device (400). The display device (400) includes an organic light emitting diode (140) which is disposed in a first pixel (PX1) configured to emit a first color light, a second pixel (PX2) configured to emit a second color light, and a third pixel (PX3) configured to emit a third color light and emits the third color light, a first color-conversion layer (151) disposed on the organic light emitting diode (140) in the first pixel (PX1), a second color-conversion layer (152) disposed on the organic light emitting diode (140) in the second pixel (PX2), a black matrix (118) disposed between the first, second and third pixels (PX1, PX2, PX3), and a light scattering layer (490) disposed only on the organic light emitting diode (140) in the third pixel (PX3), wherein a lateral surface of the light scattering layer (490) is in contact with the black matrix (118), and wherein the first color light and the second color light have a longer wavelength than the third color light.
Patent EP-4300489-A2 (EP)
Inventor: MCCALLUM MATTHEW
IPC: G10L19/018
Filed: 2018-10-23
Abstract: Methods, apparatus, systems and articles of manufacture are disclosed to reduce noise from harmonic noise sources. Example methods disclosed herein include determining a first point representing a comparatively large amplitude for a frequency value in an audio sample. Disclosed example methods also include generating a first contour trace of points having amplitude, frequency and phase values within thresholds from the first point of comparatively large amplitude. Example methods include generating a second contour trace of points having amplitude, frequency and phase values within thresholds of a second point of comparatively large amplitude. Disclosed example methods include calculating a parameter for each of the contour traces and determining if the first or second contour traces represent outliers based on the parameters. Disclosed example methods also include, in response to determining the contour to be an outlier contour trace, removing the outlier contour trace from the audio sample.
Patent EP-4307125-A2 (EP)
Inventor: HILPERT JOHANNES
IPC: G06F12/0815
Filed: 2006-06-21
Abstract: The purpose of the invention is to bridge the gap between parametric multi-channel audio coding and matrixed-surround multi-channel coding by gradually improving the sound of an up-mix signal while raising the bit-rate consumed by the side-information starting from 0 up to the bit-rates of the parametric methods. More specifically, it provides a method of flexibly choosing an "operating point" somewhere between matrixed-surround (no side-information, limited audio quality) and fully parametric reconstruction (full side-information rate required, good quality). This operating point can be chosen dynamically (i.e. varying over time) and in response to the permissible side-information rate, as it is dictated by the individual application.
Patent EP-4318173-A2 (EP)
Title: Communication device and methods
Inventor: YOUNGSAM BAE
IPC: G05G7/02
Filed: 2017-07-18
Abstract: An apparatus comprising a biocompatible housing defining a longitudinal axis; a subcutaneous sensor (14), a circuit board (26), a controller (28) and an ultrasound transmitter (30) disposed within the biocompatible housing and including a tubular piezoelectric transducer extending longitudinally along the longitudinal axis.
Patent EP-0001412-A2 (EP)
Inventor: GIESECKE HENNING DR
IPC: C07D513/10
Filed: 1978-09-18
Abstract: Neue Polyparabansäurederivate, die man durch Umsetzung von 2-Oxozolinen bzw. 2-Thiazolinen mit organischen Polyisocyanaten erhält.
Patent EP-0002535-A2 (EP)
Title: Process for the preparation of 21-hydroxy-20-methyl pregnanes
Inventor: WEBER ALFRED DR
IPC: C07J9/00
Filed: 1978-12-15
Abstract: A steroid of the formula   <IMAGE> in which @ is a single or double bond is manufactured by fermenting at pH 6 to 8 a sterol containing a free hydroxyl group in the 3-position or a corresponding compound containing another oxygen- containing function in the 3- position with a culture of a microorganism selected from Mycobacterium spec. NRRL B-3683 and B-3805 and their variants and mutants, at least a part of the fermentation being carried out in the presence of a boron- containing agent selected from borate ions and organic boron compounds.